Anxiety Depression, Depression, OCD
Conditions
Brief summary
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
Detailed description
this is a retrospective data analysis study that will utilize the already collected data as clinical care and will help understand the utilization and efficacy of various treatment options available for various mental heath conditions.
Interventions
DEVICEPatients treated with NeuroStar TMS
non-invasive brain stimulation device
DRUGPatients treated with Esketamine
nasal spray for treating depression
Sponsors
Neuronetics
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
5 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date in 2011 or later.
Exclusion criteria
• Incomplete information on treatment parameters
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change in clinical outcome scores from baseline to post treatment | 8 weeks | real-world efficacy of NeuroStar TMS as compared to Esketamine in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9 |
Countries
United States
Contacts
CONTACTNeha Goyal
CONTACTEleanor Cole, PhD
STUDY_DIRECTOREleanor Cole, PhD
Neuronetics
Outcome results
None listed